Pathology Doctors in Newark, OH Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Dr. Latha Urs, MD Pathology - Pediatric Pathology Medicare: Accepting Medicare Assignments Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 220-564-4266

Dr. Darryl Cherdron, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 740-348-4266    Fax: 740-348-4166

Dr. Lori Elwood, MD Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 220-564-4266    Fax: 220-564-4166

Audrey K Bennett, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 220-564-4266    Fax: 220-564-4166

Nicole Miller, D.O. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 1320 W Main St, Newark, OH 43055 Phone: 220-564-4218    Fax: 220-564-4217

News Archive

SGH recognized as winner of Microsoft HUG 2010 Innovation Awards

Eclipsys Corporation®, The Outcomes Company®, today announced that Singapore General Hospital, Singapore's oldest and largest acute tertiary hospital and national referral center, has been recognized as a winner of the Microsoft HUG 2010 Innovation Awards in the category of "Best Use of Clinical Records — Inpatient."

Hangovers following drinking episode appear to have modest effect on subsequent drinking

Many if not most people during their lives have experienced a hangover. Some people believe that hangovers might delay subsequent drinking through pain and discomfort, or perhaps hasten drinking to relieve hangover symptoms, known as "the hair of the dog."

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

The international research & development (R&D) consortium, AfriCoLeish, formed by six research organizations from East Africa and Europe, has launched a Phase III clinical study to address the extreme difficulty in treating visceral leishmaniasis (VL) in patients who also are HIV-positive.

Centinel Spine obtains FDA clearance for STALIF MIDLINE, MIDLINE II and MIDLINE II-Ti devices

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices receive FDA clearance for its STALIF MIDLINE, MIDLINE II, MIDLINE II-Ti (Ti-ACTIVE) devices for use with allogeneic bone graft in lumbar spinal fusion procedures.

Read more Medical News

› Verified 2 days ago